Collectively, tryptophan-derived metabolites exert pleiotropic and often contradictory effects: they can potentiate CD8+ T-cell responses and improve immunotherapy efficacy, yet also fuel tumor progression via myeloid-AhR activation or ferroptosis suppression. The gene discussed is CD8A; the disease is neoplasm.